Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.

Hack CC, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Almstedt K, Gass P, Heindl F, Brodkorb T, Willer L, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA, Nabieva N.

Breast. 2020 Jan 8;50:11-18. doi: 10.1016/j.breast.2019.12.017. [Epub ahead of print]

PMID:
31958661
2.

Draft genomes and initial characteriaztion of siderophore producing pseudomonads isolated from mine dump and mine drainage.

Hofmann M, Heine T, Schulz V, Hofmann S, Tischler D.

Biotechnol Rep (Amst). 2019 Nov 23;25:e00403. doi: 10.1016/j.btre.2019.e00403. eCollection 2020 Mar.

3.

Algorithms for joint activity-attenuation estimation from positron emission tomography scatter.

Berker Y, Schulz V, Karp JS.

EJNMMI Phys. 2019 Oct 28;6(1):18. doi: 10.1186/s40658-019-0254-y.

4.

Spiral blurring correction with water-fat separation for magnetic resonance fingerprinting in the breast.

Nolte T, Gross-Weege N, Doneva M, Koken P, Elevelt A, Truhn D, Kuhl C, Schulz V.

Magn Reson Med. 2020 Apr;83(4):1192-1207. doi: 10.1002/mrm.27994. Epub 2019 Oct 21.

PMID:
31631385
5.

Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC.

Toth RK, Tran JD, Muldong MT, Nollet EA, Schulz VV, Jensen CC, Hazlehurst LA, Corey E, Durden D, Jamieson C, Miranti CK, Warfel NA.

Am J Clin Exp Urol. 2019 Aug 15;7(4):297-312. eCollection 2019.

6.

A Unique Epigenomic Landscape Defines Human Erythropoiesis.

Schulz VP, Yan H, Lezon-Geyda K, An X, Hale J, Hillyer CD, Mohandas N, Gallagher PG.

Cell Rep. 2019 Sep 10;28(11):2996-3009.e7. doi: 10.1016/j.celrep.2019.08.020.

7.

Multifrequency magnetic particle imaging enabled by a combined passive and active drive field feed-through compensation approach.

Pantke D, Holle N, Mogarkar A, Straub M, Schulz V.

Med Phys. 2019 Sep;46(9):4077-4086. doi: 10.1002/mp.13650. Epub 2019 Jul 16.

8.

Aberrant splicing contributes to severe α-spectrin-linked congenital hemolytic anemia.

Gallagher PG, Maksimova Y, Lezon-Geyda K, Newburger PE, Medeiros D, Hanson RD, Rothman J, Israels S, Wall DA, Sidonio RF Jr, Sieff C, Gowans LK, Mittal N, Rivera-Santiago R, Speicher DW, Baserga SJ, Schulz VP.

J Clin Invest. 2019 Apr 30;129(7):2878-2887. doi: 10.1172/JCI127195.

9.

MKL1-actin pathway restricts chromatin accessibility and prevents mature pluripotency activation.

Hu X, Liu ZZ, Chen X, Schulz VP, Kumar A, Hartman AA, Weinstein J, Johnston JF, Rodriguez EC, Eastman AE, Cheng J, Min L, Zhong M, Carroll C, Gallagher PG, Lu J, Schwartz M, King MC, Krause DS, Guo S.

Nat Commun. 2019 Apr 12;10(1):1695. doi: 10.1038/s41467-019-09636-6.

10.

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.

Nabieva N, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb T, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA.

Int J Cancer. 2019 Oct 15;145(8):2114-2121. doi: 10.1002/ijc.32294. Epub 2019 Apr 2.

PMID:
30901076
11.

PET performance evaluation of the small-animal Hyperion IID PET/MRI insert based on the NEMA NU-4 standard.

Hallen P, Schug D, Weissler B, Gebhardt P, Salomon A, Kiessling F, Schulz V.

Biomed Phys Eng Express. 2018 Nov;4(6):065027. doi: 10.1088/2057-1976/aae6c2. Epub 2018 Oct 24.

12.

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.

Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, Hein A, Häberle L, Jud SM, Lux MP, Janni W, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kümmel S, Martin B, Thomssen C, Graf H, Wolf C, Bayer CM, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb TF, Nabieva N, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Wallwiener D, Rack B, Fehm T, Rody A, Maass N, Beckmann MW, Fasching PA, Rauh C.

Breast Cancer Res Treat. 2019 Apr;174(2):453-461. doi: 10.1007/s10549-018-05115-6. Epub 2019 Jan 2.

PMID:
30603996
13.

MR image corrections for PET-induced gradient distortions.

Gross-Weege N, Nolte T, Schulz V.

Phys Med Biol. 2019 Jan 16;64(2):02NT03. doi: 10.1088/1361-6560/aaf97a.

PMID:
30562166
14.

MRTFA augments megakaryocyte maturation by enhancing the SRF regulatory axis.

Rahman NT, Schulz VP, Wang L, Gallagher PG, Denisenko O, Gualdrini F, Esnault C, Krause DS.

Blood Adv. 2018 Oct 23;2(20):2691-2703. doi: 10.1182/bloodadvances.2018019448.

15.

Advance care planning in community dwellers: A constructivist grounded theory study of values, preferences and conflicts.

Taneja R, Faden LY, Schulz V, Rawal A, Miller K, Bishop KA, Lingard L.

Palliat Med. 2019 Jan;33(1):66-73. doi: 10.1177/0269216318803487. Epub 2018 Oct 4. No abstract available.

PMID:
30284950
16.

Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial.

Min KC, Bondiskey P, Schulz V, Woo T, Assaid C, Yu W, Reynders T, Declercq R, McCrea J, Dennie J, Adkinson F, Shepherd G, Gutstein DE.

Br J Anaesth. 2018 Oct;121(4):749-757. doi: 10.1016/j.bja.2018.05.056. Epub 2018 Aug 23.

17.

Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs.

Kim ST, Choi JY, Lainez B, Schulz VP, Karas DE, Baum ED, Setlur J, Gallagher PG, Craft J.

J Immunol. 2018 Sep 1;201(5):1359-1372. doi: 10.4049/jimmunol.1701217. Epub 2018 Jul 20.

18.

Joint Reconstruction of Tracer Distribution and Background in Magnetic Particle Imaging.

Straub M, Schulz V.

IEEE Trans Med Imaging. 2018 May;37(5):1192-1203. doi: 10.1109/TMI.2017.2777878.

PMID:
29727282
19.

OR2H2 regulates the differentiation of human myoblast cells by its ligand aldehyde 13-13.

Kalbe B, Osterloh M, Schulz VM, Altmüller J, Becker C, Osterloh S, Hatt H.

Arch Biochem Biophys. 2018 May 1;645:72-80. doi: 10.1016/j.abb.2018.03.017. Epub 2018 Mar 17.

PMID:
29559321
20.

Numerical algorithms for scatter-to-attenuation reconstruction in PET: empirical comparison of convergence, acceleration, and the effect of subsets.

Berker Y, Karp JS, Schulz V.

IEEE Trans Radiat Plasma Med Sci. 2017 Sep;1(5):426-434. doi: 10.1109/TNS.2017.2713521. Epub 2017 Jun 8.

21.

Correction: STAT4 and T-bet control follicular helper T cell development in viral infections.

Weinstein JS, Laidlaw BJ, Lu Y, Wang JK, Schulz VP, Li N, Herman EI, Kaech SM, Gallagher PG, Craft J.

J Exp Med. 2018 Mar 5;215(3):999. doi: 10.1084/jem.2017045702062018c. Epub 2018 Feb 13. No abstract available.

22.

Characterization methods for comprehensive evaluations of shielding materials used in an MRI.

Gross-Weege N, Dey T, Gebhardt P, Schug D, Weissler B, Schulz V.

Med Phys. 2018 Apr;45(4):1415-1424. doi: 10.1002/mp.12762. Epub 2018 Feb 26.

PMID:
29363769
23.

Challenges facing palliative neurology practice: A qualitative analysis.

Gofton TE, Chum M, Schulz V, Gofton BT, Sarpal A, Watling C.

J Neurol Sci. 2018 Feb 15;385:225-231. doi: 10.1016/j.jns.2017.12.008. Epub 2017 Dec 7.

PMID:
29277430
24.

STAT4 and T-bet control follicular helper T cell development in viral infections.

Weinstein JS, Laidlaw BJ, Lu Y, Wang JK, Schulz VP, Li N, Herman EI, Kaech SM, Gallagher PG, Craft J.

J Exp Med. 2018 Jan 2;215(1):337-355. doi: 10.1084/jem.20170457. Epub 2017 Dec 6. Erratum in: J Exp Med. 2018 Feb 13;:.

25.

Palliative Medicine-Becoming a Subspecialty of the Royal College of Physicians and Surgeons of Canada.

Pilkey J, Downar J, Dudgeon D, Herx L, Oneschuk D, Schroder C, Schulz V.

J Palliat Care. 2017 Jul/Oct;32(3-4):113-120. doi: 10.1177/0825859717741027. Epub 2017 Nov 13.

PMID:
29129136
26.

Molecular basis of tactile specialization in the duck bill.

Schneider ER, Anderson EO, Mastrotto M, Matson JD, Schulz VP, Gallagher PG, LaMotte RH, Gracheva EO, Bagriantsev SN.

Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):13036-13041. doi: 10.1073/pnas.1708793114. Epub 2017 Nov 6.

27.

Beyond Simple Planning: Existential Dimensions of Conversations With Patients at Risk of Dying From Heart Failure.

Schulz VM, Crombeen AM, Marshall D, Shadd J, LaDonna KA, Lingard L.

J Pain Symptom Manage. 2017 Nov;54(5):637-644. doi: 10.1016/j.jpainsymman.2017.07.041. Epub 2017 Aug 5.

28.

Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

Glogowska E, Schneider ER, Maksimova Y, Schulz VP, Lezon-Geyda K, Wu J, Radhakrishnan K, Keel SB, Mahoney D, Freidmann AM, Altura RA, Gracheva EO, Bagriantsev SN, Kalfa TA, Gallagher PG.

Blood. 2017 Oct 19;130(16):1845-1856. doi: 10.1182/blood-2017-05-786004. Epub 2017 Jul 17.

29.

Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of Raltegravir.

Krishna R, Rizk ML, Larson P, Schulz V, Kesisoglou F, Pop R.

Clin Pharmacol Drug Dev. 2018 Feb;7(2):196-206. doi: 10.1002/cpdd.358. Epub 2017 Apr 17.

PMID:
28419778
30.

Fluorinated polyurethane scaffolds for 19F magnetic resonance imaging.

Lammers T, Mertens ME, Schuster P, Rahimi K, Shi Y, Schulz V, Kuehne AJC, Jockenhoevel S, Kiessling F.

Chem Mater. 2017 Apr 11;29(7):2669-2671. doi: 10.1021/acs.chemmater.6b04649.

31.

A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.

Frank SB, Schulz VV, Miranti CK.

BMC Biotechnol. 2017 Feb 28;17(1):24. doi: 10.1186/s12896-017-0341-x.

32.

A variant Sp1 (R218Q) transcription factor might enhance HbF expression in β0 -thalassaemia homozygotes.

Jiang Z, Luo HY, Farrell JJ, Zhang Z, Schulz VP, Albarawi D, Steinberg MH, Al-Allawi NAS, Gallagher PG, Forget BG, Chui DHK.

Br J Haematol. 2018 Mar;180(5):755-757. doi: 10.1111/bjh.14445. Epub 2017 Feb 27. No abstract available.

PMID:
28240767
33.

Distinct roles for TET family proteins in regulating human erythropoiesis.

Yan H, Wang Y, Qu X, Li J, Hale J, Huang Y, An C, Papoin J, Guo X, Chen L, Kang Q, Li W, Schulz VP, Gallagher PG, Hillyer CD, Mohandas N, An X.

Blood. 2017 Apr 6;129(14):2002-2012. doi: 10.1182/blood-2016-08-736587. Epub 2017 Feb 6.

34.

Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis.

Yang E, Voelkel EB, Lezon-Geyda K, Schulz VP, Gallagher PG.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26444. Epub 2017 Jan 25.

35.

Pulling together and pulling apart: influences of convergence and divergence on distributed healthcare teams.

Lingard L, Sue-Chue-Lam C, Tait GR, Bates J, Shadd J, Schulz V; Heart Failure/Palliative Care Teamwork Research Group.

Adv Health Sci Educ Theory Pract. 2017 Dec;22(5):1085-1099. doi: 10.1007/s10459-016-9741-2. Epub 2017 Jan 23.

36.

Helional-induced activation of human olfactory receptor 2J3 promotes apoptosis and inhibits proliferation in a non-small-cell lung cancer cell line.

Kalbe B, Schulz VM, Schlimm M, Philippou S, Jovancevic N, Jansen F, Scholz P, Lübbert H, Jarocki M, Faissner A, Hecker E, Veitinger S, Tsai T, Osterloh S, Hatt H.

Eur J Cell Biol. 2017 Jan;96(1):34-46. doi: 10.1016/j.ejcb.2016.11.004. Epub 2016 Dec 5.

PMID:
27939274
38.

Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda Protein.

Nemec AA, Bush KB, Towle-Weicksel JB, Taylor BF, Schulz V, Weidhaas JB, Tuck DP, Sweasy JB.

Mol Cancer Res. 2016 Nov;14(11):1068-1077. Epub 2016 Sep 12.

39.

Novel Gastroretentive Controlled Release Formulations for Once-Daily Administration: Assessment of Clinical Feasibility and Formulation Concept for Raltegravir.

Krishna R, Rizk ML, Larson PJ, Schulz V, Friedman E, Gupta P, Kesisoglou F, Connor A, McDermott J, Smith R, Evans P.

Ther Innov Regul Sci. 2016 Nov;50(6):777-790. doi: 10.1177/2168479016657130. Epub 2016 Jul 19.

PMID:
30231748
40.

[20th Anniversary of the German Tuberculosis Archive].

Schulz V.

Pneumologie. 2016 Oct;70(10):657-659. Epub 2016 Oct 10. German. No abstract available.

41.

Olfactory Receptors Modulate Physiological Processes in Human Airway Smooth Muscle Cells.

Kalbe B, Knobloch J, Schulz VM, Wecker C, Schlimm M, Scholz P, Jansen F, Stoelben E, Philippou S, Hecker E, Lübbert H, Koch A, Hatt H, Osterloh S.

Front Physiol. 2016 Aug 4;7:339. doi: 10.3389/fphys.2016.00339. eCollection 2016.

42.

Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1.

Tesfay L, Schulz VV, Frank SB, Lamb LE, Miranti CK.

Mol Biol Cell. 2016 Aug 1;27(15):2493-504. doi: 10.1091/mbc.E15-09-0649. Epub 2016 Jun 15.

43.

Maximum likelihood positioning algorithm for high-resolution PET scanners.

Gross-Weege N, Schug D, Hallen P, Schulz V.

Med Phys. 2016 Jun;43(6):3049-3061. doi: 10.1118/1.4950719.

PMID:
27277052
44.

CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells.

Steiner LA, Schulz V, Makismova Y, Lezon-Geyda K, Gallagher PG.

PLoS One. 2016 May 24;11(5):e0155378. doi: 10.1371/journal.pone.0155378. eCollection 2016.

45.

Setd1a and NURF mediate chromatin dynamics and gene regulation during erythroid lineage commitment and differentiation.

Li Y, Schulz VP, Deng C, Li G, Shen Y, Tusi BK, Ma G, Stees J, Qiu Y, Steiner LA, Zhou L, Zhao K, Bungert J, Gallagher PG, Huang S.

Nucleic Acids Res. 2016 Sep 6;44(15):7173-88. doi: 10.1093/nar/gkw327. Epub 2016 May 3.

46.

FPGA-based RF interference reduction techniques for simultaneous PET-MRI.

Gebhardt P, Wehner J, Weissler B, Botnar R, Marsden PK, Schulz V.

Phys Med Biol. 2016 May 7;61(9):3500-26. doi: 10.1088/0031-9155/61/9/3500. Epub 2016 Apr 6.

47.

System Characterization of a Highly Integrated Preclinical Hybrid MPI-MRI Scanner.

Franke J, Heinen U, Lehr H, Weber A, Jaspard F, Ruhm W, Heidenreich M, Schulz V.

IEEE Trans Med Imaging. 2016 Sep;35(9):1993-2004. doi: 10.1109/TMI.2016.2542041. Epub 2016 Mar 14.

PMID:
26991821
48.

Initial PET performance evaluation of a preclinical insert for PET/MRI with digital SiPM technology.

Schug D, Lerche C, Weissler B, Gebhardt P, Goldschmidt B, Wehner J, Dueppenbecker PM, Salomon A, Hallen P, Kiessling F, Schulz V.

Phys Med Biol. 2016 Apr 7;61(7):2851-78. doi: 10.1088/0031-9155/61/7/2851. Epub 2016 Mar 17.

49.

Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.

Melinyshyn AN, Gofton TE, Schulz V.

Neurology. 2016 May 3;86(18):1726-8. doi: 10.1212/WNL.0000000000002541. Epub 2016 Mar 11.

50.

Measurement of the point spread function of a pixelated detector array.

Ritzer C, Hallen P, Schug D, Schulz V.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A10. doi: 10.1186/2197-7364-2-S1-A10. No abstract available.

Supplemental Content

Loading ...
Support Center